TrialFind
Saved trials
Back to results
Terminated
Phase 1
Phase 2
Grapiprant and Eribulin for the Treatment of Metastatic Inflammatory Breast Cancer
NCT05041101
What is this trial?
Generating plain-language summary...
Am I eligible?
Generating eligibility summary...
What's involved?
Summarizing study design...
Where and how to apply
Primary location
M D Anderson Cancer Center
Houston, Texas, United States
View on ClinicalTrials.gov
Official details
Grapiprant and Eribulin for the Treatment of Metastatic Inflammatory Breast Cancer — TrialFind